Skip to content

Euflexxa

by Bio-Technology General (Israel) Ltd. Israel EUDAMED

Ref 6301182061Model EUFLEXXA 1% Sodium Hyaluronate EMDN V9099

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-07640128548409 Basic UDI-DIDate29 Jan 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
EUFLEXXA 1% Sodium Hyaluronate, 6301182061
Primary DI / UDI-DI
07640128548409
Basic UDI-DI
B-07640128548409
EMDN Code
V9099 Various devices not included in other classes - other
Device Class
Class III
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
IL-MF-000003764
Authorised representative
Ferring Pharmaceuticals A/S DK-AR-000001206

Related devices

Category: Device sterilization/disinfection container, reusable

Other devices from Bio-Technology General (Israel) Ltd.

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
Other properties (11)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED ebd62b84-d0af-439a-a50c-9e0a74eba3f0 61 fields · synced 24 Oct 2026